Two Owners of New Jersey Pharmaceutical Marketing Company Admit Role in $38 Million Compounding Fraud Scheme

NEWARK, N.J. – Two owners of a New Jersey pharmaceutical marketing company admitted their roles in a $38 million compounded medication health care fraud scheme, U.S. Attorney Philip R. Sellinger…